Tag - shire

 
 

SHIRE

Japan Times
BUSINESS / Companies
Jan 9, 2019
Takeda's CEO says it needs to sell assets quickly to cut debt
The sooner, the better.
Japan Times
BUSINESS
Jan 7, 2019
With nearly $900 billion in cash at the ready, Japan's M&A spending spree likely to continue
Japan outmuscled China to dominate mergers and acquisitions in Asia last year, and with companies in possession of more than $890 billion in cash, the spending spree is likely to continue in 2019.
Japan Times
BUSINESS / Companies / ANALYSIS
Dec 6, 2018
Takeda downgrade looms after shareholders approve Shire deal
Takeda Pharmaceutical Co. shareholders' approval of the $62 billion (about ¥7 trillion) acquisition of Shire PLC is good news for its bosses' ambitions to build a global drug giant — but bad news for its credit ratings.
Japan Times
BUSINESS / Companies
Nov 21, 2018
With EU approval secured, Takeda clears last regulatory hurdle for $62 billion Shire purchase
Takeda Pharmaceutical Co. has won European Union approval for its takeover of Shire PLC, clearing the last major regulatory hurdle for the $62 billion acquisition and paving the way to a shareholder vote.
Japan Times
BUSINESS / Companies
Nov 6, 2018
Japan's Takeda Pharmaceutical pushes back as dissident shareholders seek to stop Shire deal
Takeda Pharmaceutical Co. Chief Executive Officer Christophe Weber pushed back against dissident shareholders seeking to stop the drugmaker's acquisition of Shire PLC, saying he won't release minutes of boardroom discussions.
Japan Times
BUSINESS / Companies
Oct 29, 2018
Takeda may sell some European over-the-counter assets as it seeks to slash debt
Takeda Pharmaceutical Co. is considering a sale of assets from its over-the-counter business in Europe, as the drugmaker pursues ways to cut debt after its $62 billion takeover of Shire PLC, people familiar with the matter said.
Japan Times
BUSINESS / Companies
Sep 24, 2018
Key investor in Japan's Takeda reportedly skeptical about Shire takeover
One of the top 10 shareholders in drugmaker Takeda Pharmaceutical Co. is "skeptical" about the value that will be created from the group's $62 billion takeover of rare-disease specialist Shire PLC, the Sunday Times reported, citing the unidentified investor.
Japan Times
BUSINESS / Companies
Jul 18, 2018
Takeda bets on China for global growth, seeing the country as 'on a par' with the U.S. and Europe
Takeda Pharmaceutical Co. sees China becoming a "core country" for its global growth strategy, and is optimistic its $62 billion (¥6.94 trillion) acquisition of Shire PLC will win approval by the country's regulators.
Japan Times
BUSINESS / Companies
Jun 13, 2018
Takeda CEO talks about Shire acquisition and the future integration of the firms after Japan's biggest outbound takeover
Christophe Weber says growth and innovation are the metrics for success in Takeda Pharmaceutical Co.'s $62 billion purchase of Shire PLC. The first order of business is bringing global shareholders around to Japan's biggest-ever outbound takeover.
BUSINESS / Companies
May 24, 2018
Takeda invites banks to join $31 billion loan for Shire deal
Takeda Pharmaceutical Co. has invited Japanese and overseas banks to participate in the syndication of the $30.85 billion (¥3.362 trillion) loan to back its $62 billion purchase of Shire Plc, according to people familiar with the matter.
Japan Times
BUSINESS / Companies / FOCUS
May 11, 2018
Whisky-inspired code names cloaked Takeda's $62 billion Shire gamble in secrecy — until cover was blown
Takeda Pharmaceutical Co.'s ambitions to expand in the lucrative U.S. health care market led the drugmaker to begin a painstaking examination of Shire PLC's assets more than two years prior to striking a $62 billion deal.
Japan Times
BUSINESS / Companies / ANALYSIS
Apr 26, 2018
Shire bid marks Takeda's latest and biggest push for global status
Takeda Pharmaceutical Co. Ltd..'s $64 billion bid for London-listed rare-disease specialist Shire PLC bolsters its credentials as Japan's most outward-facing drugs firm, a mold-breaking image that has been more than a decade in the making.
BUSINESS / Companies
Apr 21, 2018
Japanese drugmaker Takeda adds more cash to Shire bid, sending offer past $60 billion
Takeda Pharmaceutical Co. sweetened its offer for drugmaker Shire PLC to more than $60 billion after three prior bids were rejected, wooing investors in the U.S. company with a higher cash component.
Japan Times
BUSINESS / Companies
Mar 29, 2018
Takeda shares slide amid $50 billion takeover bid for Shire
Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ¥5.3 trillion), which would be the Japanese company’s biggest takeover ever.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?